BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
See today's BioWorld
Home
» FDA maps out the route to market for interchangeables
To read the full story,
subscribe
or
sign in
.
FDA maps out the route to market for interchangeables
Jan. 18, 2017
By
Mari Serebrov
No Comments
At last, the FDA has delivered on its promise to issue guidance on interchangeability, opening the door to automatic pharmacy substitution and the closest thing possible to a generic biologic.
BioWorld